These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 605153)

  • 21. Effect of spironolactone on aldosterone regulation in man.
    Gaillard RC; Riondel AM; Chabert P; Vallotton MB
    Clin Sci (Lond); 1980 Mar; 58(3):227-33. PubMed ID: 6244912
    [No Abstract]   [Full Text] [Related]  

  • 22. Potassium-sparing diuretics.
    Gussin RZ
    J Clin Pharmacol; 1977 Oct; 17(10 Pt 2):651-62. PubMed ID: 915027
    [No Abstract]   [Full Text] [Related]  

  • 23. Spironolactone and triamterene in volume-dependent essential hypertension.
    DeCarvalho JG; Emery AC; Frohlich ED
    Clin Pharmacol Ther; 1980 Jan; 27(1):53-6. PubMed ID: 6985854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current data on the pharmacology of diuretics].
    Giroud JP; Schmitt H
    Therapie; 1968; 23(2):261-327. PubMed ID: 4302704
    [No Abstract]   [Full Text] [Related]  

  • 26. Renin-aldosterone profiling in hypertension.
    Mitchell JR; Taylor AA; Pool JL; Lake CR; Rollins DE; Bartter FC
    Ann Intern Med; 1977 Nov; 87(5):596-312. PubMed ID: 335942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of spironolactone on endogenous steroid metabolism in man.
    Abshagen U; Spörl S; Schöneshöfer M; L'age M; Rennekamp H; Oelkers W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():307s-310s. PubMed ID: 1071632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological studies on diuretics. 6. Actions of various diuretics on experimental nephrotic rats].
    Suzuki Y; Ina K; Yamagami I
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):739-48. PubMed ID: 4797064
    [No Abstract]   [Full Text] [Related]  

  • 30. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J; Albornoz F; Yu C; Byrne DW; Vaughan DE; Brown NJ
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension.
    Laragh JH; Sealey J; Brunner HR
    Am J Med; 1972 Nov; 53(5):649-63. PubMed ID: 4342888
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes of electrolyte excretion, renin activity, angiotensin-II and aldosterone concentrations during administration of 3-amino-1-(3,4-dichloro-a-methyl-benzyl)-2-pyrazolin-5-one (Bay g 2821).
    Schnurr E; Küppers H
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):453-6. PubMed ID: 511420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The renal regulation of sodium and potassium in patients with chronic renal failure (CRF) and the effect of diuretics on the excretion of these ions.
    Kleeman CR; Okun R; Heller RJ
    Ann N Y Acad Sci; 1966 Nov; 139(2):520-39. PubMed ID: 5230293
    [No Abstract]   [Full Text] [Related]  

  • 34. Laxative-induced hypokalemia, sodium depletion and hyperreninemia. Effects of potassium and sodium replacement on the renin-angiotensin-aldosterone system.
    Fleming BJ; Genuth SM; Gould AB; Kamionkowski MD
    Ann Intern Med; 1975 Jul; 83(1):60-2. PubMed ID: 1147438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacology of potassium-sparing diuretics].
    Dominiak P
    Praxis (Bern 1994); 1997 Apr; 86(14):552-5. PubMed ID: 9198848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract]   [Full Text] [Related]  

  • 37. An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone.
    Desmit EM; Cost WS; Brown JJ; Fraser R; Lever AF; Robertson JI
    Acta Endocrinol (Copenh); 1970 May; 64(1):75-94. PubMed ID: 4318377
    [No Abstract]   [Full Text] [Related]  

  • 38. A role for the adrenal renin-angiotensin system in the regulation of potassium-stimulated aldosterone production.
    Nakamaru M; Misono KS; Naruse M; Workman RJ; Inagami T
    Endocrinology; 1985 Nov; 117(5):1772-8. PubMed ID: 3899615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Exchangeable sodium, total-body potassium, plasma volume, and hypotensive effect of various diuretics in patients with essential hypertension and low plasma renin level (author's transl)].
    Distler A; Keim HJ; Philipp T; Philippi A; Walter U; Werner E
    Dtsch Med Wochenschr; 1974 Apr; 99(17):864-9. PubMed ID: 4834874
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).
    Brackett NC; Koppel M; Randall RE; Nixon WP
    Am J Med; 1968 May; 44(5):803-19. PubMed ID: 4297214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.